Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

The largest, most ethnically diverse, study of its kind has flagged hundreds of genetic variants that play a role in ...

The Food and Drug Administration (FDA) has approved Spravato, a nasal spray developed by Johnson & Johnson, as a standalone ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

Spravato is a first-of-its-kind medication to help manage treatment-resistant depression, according to Johnson & Johnson.

But many people who take daily medications are unaware that certain drugs in their pill box can also increase their risk of ...

This paper reviews recent findings on the pharmacogenetics of antidepressant drugs and future clinical applications. Ultimately, these studies should lead to the use of genetic testing to guide ...

They are now the most commonly prescribed antidepressant medications. They are prescribed to treat depression but are also used to treat a broader range of depressive disorders, anxiety disorders, and ...

Studies show that antidepressants don’t always work. One psychologist explains how to take control of negative thoughts ...

Stimulant medications are considered the first-line treatment for ADHD for some very good reasons. Here are 6 things to know ...

Scientists uncover rapid-acting, low-side-effect antidepressant target New study highlights the molecular and cellular mechanisms underlying the antidepressant effect of delta opioid receptor agonists ...

Brooke Shields has spoken out on her 2005 feud with Tom Cruise over his comments about her postpartum depression medication ...